Riskpilot← Back to searchSign inGet full accessBonsa Medica AB
ABActiveOrg 5569716789Ångbåtsbryggan 16 BGeneral medical practice activities · NACE 8621Est. 20140 employees
Revenue 2025
SEK 0
EBITDA margin
—
+13% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -15K
+65% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -14K | +13% |
| Net profit | SEK -15K | +65% |
| Total assets | SEK 111K | -26% |
| Equity | SEK 111K | -11% |
| Employees | 0 | — |
Legal name
Bonsa Medica AB
Org number
5569716789
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 maj 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom hälso- och sjukvård, främst primärvård samt därtill hörande utbildningsverksamhet.
Address
Ångbåtsbryggan 16 B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 56 | 546 | 173 | 3 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −85 | 316 | 122 | −16 | −14 |
| Depreciation & amort. | −0 | −0 | −8 | −34 | −0 |
| EBIT | −85 | 316 | 114 | −50 | −14 |
| Net financials | −1 | 1 | 6 | 2 | −1 |
| Profit before tax | −85 | 317 | 115 | −43 | −15 |
| Tax | 17 | −48 | −41 | −0 | −0 |
| Net profit | −68 | 269 | 74 | −43 | −15 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 46 | 474 | 285 | 149 | 111 |
| Equity | 25 | 294 | 168 | 125 | 111 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 | 180 | 113 | 24 | 0 |
| Total debt | 21 | 180 | 113 | 24 | — |
EBITDA margin
-1400000.0%
This company
15.8%
Market median
-8860859% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-13.5%
This company
18.4%
Market median
-173% vs market
20212025
Net profit margin
-1500000.0%
This company
8.1%
Market median
-18518619% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HS Chief Executive Officer | Chief Executive Officer | 2025 |
KM Authorized Recipient of Service | Authorized Recipient of Service | 2025 |
| Former (1) | ||
KE Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bonsa Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kaj Erol Åhsberg | Authorized Recipient of Service | 0 companies |
| Hanna Sofie Åsberg | Chief Executive Officer | 0 companies |
| Karin Mary Christina Neuman | Authorized Recipient of Service | 0 companies |
| Bermet Morén | Deputy Board Member | 0 companies |